This inventor holds 1 USPTO granted patent. Top assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yangjian Liu: Innovator in Nucleic Acid Technology
Introduction
Yangjian Liu is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of nucleic acid technology, particularly in enhancing the stability and efficiency of mRNA.
Latest Patents
Yangjian Liu holds a patent for a C6'-substituted locked nucleic acid-modified cap analog. This innovative cap analog improves the stability of mRNA and enhances its translation efficiency. His work in this area is crucial for advancements in genetic research and therapeutic applications.
Career Highlights
Yangjian Liu is associated with Hangzhou Tianlong Pharmaceutical Co., Ltd., where he applies his expertise in nucleic acid technology. His role in the company allows him to contribute to the development of cutting-edge pharmaceutical solutions.
Collaborations
Yangjian Liu collaborates with notable colleagues, including Huajie Huang and Chuan Gao. Their combined efforts in research and development foster innovation in their respective fields.
Conclusion
Yangjian Liu's contributions to nucleic acid technology and his innovative patent demonstrate his commitment to advancing scientific research. His work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile